Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Stanford's Free Electron Laser Blasts Away | Main | Marcia Angell's Interview: I Just Can't »

December 3, 2012

Fluorous Technologies Is No More

Email This Entry

Posted by Derek

Word comes that Fluorous is shutting down. The company had been trying for several years to make a go of it with its polyfluorinated materials, used for purification and reaction partitioning, but the commercial side of the business has apparently been struggling for a while. It's a tough market, and there hasn't, as far as I know, been what the software people would call a "killer app" for fluorous techniques - they're interested, often useful, but it's been hard to persuade enough people to take a crack at them.

The company is still taking orders for its remaining stock, and the link above will allow you to download their database of literature references for fluorous techniques, among other things. I wish the people involved the best, and I wish that things had worked out better.

Comments (7) + TrackBacks (0) | Category: Business and Markets | Chemical News


COMMENTS

1. RB Woodweird on December 3, 2012 10:59 AM writes...

Is there more to the story? We all know of tiny companies which manage to survive selling specialized reagents/equipment. Why could this one not find the proper size it needs to be to operate in the black? Why break it all up?

Permalink to Comment

2. Leedschemist on December 3, 2012 11:36 AM writes...

Sad times, used their stuff a lot during my PhD. F-SPE worked really nicely for me and many others in our group.

Permalink to Comment

3. David Formerly Known as a Chemist on December 3, 2012 3:51 PM writes...

I never personally knew anyone that used this technology. It looked interested back when it was introduced, somewhat at the tail-end of the combichem era, and maybe would have blossomed had combichem not fallen out of favor. By the time fluorous technology was commercialized companies had already invested in mass-triggered HPLC fractionation and other purification techniques. It's too bad but frankly I'm surprised they survived as long as they did, the market was just too niche.

Permalink to Comment

4. Nick K on December 3, 2012 8:47 PM writes...

This is rotten news. FTI had a really interesting technology and deserved a better fate than this.

Permalink to Comment

5. curryworks on December 4, 2012 7:41 AM writes...

They were essentially making money but not growing.

Permalink to Comment

6. The Heterocyclist on December 5, 2012 12:59 PM writes...

When I was at Berry & Associates (a small nucleic acids chemistry company) we developed phosphoramidites for introducing fluorous tags into oligonucleotides for purification or permanent fluorous tagging. The technology worked very well and it was great working with the people at FTI. The reagents were steady sellers (and as far as I know, still are), but no killer app arose, at least during my time there. I'm sad to see them go.

Permalink to Comment

7. Jimmy Lee on February 26, 2013 9:36 PM writes...

Hi, there, there is any person still in Fluorous Technologies (Tracey Zimmerman [t.zimmerman@fluorous.com])

Because just few months ago, I contacted with Tracey and she told me that she is not in that company any more , asking I contact with Patti Peiffer at p.peiffer@fluorous.com or 412-826-3050.

But it seems Peiffer not available ..

I want to buy 160grams of 3-(Perfluorooctyl)propyl iodide ; CAS#200112-75-0 ; Your Cat# F017002 , this is a rush order

I knew few months ago, they still had it more than 100grams stock , Derek said in here they are still trying to sell remain of chemicals , how can I contact with any person in this company, anybody can help me on this case !
Thanks

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Update on Alnylam (And the Direction of Things to Come)
There Must Have Been Multiple Chances to Catch This
Weirdly, Tramadol Is Not a Natural Product After All
Thiola, Retrophin, Martin Shkrell, Reddit, and More
The Most Unconscionable Drug Price Hike I Have Yet Seen
Clinical Trial Fraud
Grinding Up Your Reactions
Peer Review, Up Close and Personal